4,4',4''-(1,3,5-Triazine-2,4,6-triyl)trianiline>98.0%(HPLC)5g

3-(3,4,5-trimethoxyphenyl)-1{H}-pyrazole-5-carboxylic acid, 95.0%, 1g

2'-O-MOE-5-Me-rU, ?97.0%, 100mg

4-(2-oxo-1,2-dihydropyridin-1-yl)butanoic acid, 95.0%, 500mg

5'''-(4''-CARBOXY-[1,1':4',1''-TERPHENYL]-4-YL)-[1,1':4',1'':4'',1''':3''',1'''':4'''',1''''':4''''',1''''''-SEPTIPHENYL]-4,4''''''-DICARBOXYLIC ACID, 95%, 500mg

6-Amino-5-(2-chloroacetyl)-1-cyclopropyl-1,2,3,4-tetrahydropyrimidine-2,4-dione, 98%, 100mg

8-Hydroxyquinoline-2-carboxaldehyde, 95.0%, 100g

2-bromo-5-ethoxy-4-methoxybenzaldehyde, 5g

6-AZASPIRO[2.5]OCTANE, 97.0%, 250mg

GC capillary column ROTI®Cap-5, 30 m, 0.32 mm, 0.10 µm, 1 Piece(s)

1-(AZETIDIN-1-YL)-3-CHLOROPROPAN-1-ONE, 95.0%, 250mg

2,6-Diethylphenol, 95.0%, 1g

2-(6-Chloro-3-oxo-2H-benzo[b][1,4]oxazin-4(3H)-yl)acetic acid, 98%, 1g